South & Central America Cell and Gene Therapy Market Forecast to 2031 - Regional Analysis - by Type (Cell Therapy {Allogeneic, Autologous, and Viral Vectors}, and Gene Therapy {Non-viral Vectors, and Viral Vectors}), Services (Process Development, cGMP Manufacturing, Regulatory Services, and Bioassay Services), Scale (Pre-Commercial/R&D Manufacturing, and Commercial Scale Manufacturing), Service Providers (CDMOs and CMOs), and End User (Contract Research Organizations, Pharmaceutical and Biopharmaceutical Companies, and Academic & Research Institutes)
The South & Central America cell and gene therapy market was valued at US$ 67.28 million in 2023 and is projected to reach US$ 184.80 million by 2030; it is estimated to record a CAGR of 13.5% from 2023 to 2031.
Strategic Initiatives by Companies Boost South & Central America Cell and Gene Therapy Market
Many companies involved in manufacturing cell and gene therapy products focus on collaborations, expansions, agreements, partnerships, new product launches, and other strategic developments. These strategic initiatives help them improve sales, expand geographic reach, and enhance capacities to cater to a large customer base. A few of the significant developments in the cell and gene therapy market are as In March 2022, Cellevolve Bio partnered with Seattle Children’s Therapeutics to develop and commercialize new multiplex CARs for pediatric cancers. With this collaboration, the companies will focus on the BrainChild research program—a suite of five multiplex CARs—to treat pediatric central nervous system (CNS) malignancies. They aim to leverage the Seattle Children’s Cure Factory facility to conduct early clinical GMP research on new CARs. In March 2022, Twist Bioscience Corporation and Kriya Therapeutics, Inc. entered an antibody discovery agreement for antibodies delivered using adeno-associated viral (AAV) gene therapy in therapeutic oncology applications. Also, the companies aim to combine Twist’s antibody libraries with Kriya’s proprietary vector engineering platform to discover novel antibodies against specific targets of interest to be delivered with Kriya’s gene therapy technology. In January 2022, FUJIFILM Corporation agreed to acquire a cell therapy manufacturing facility from Atara Biotherapeutics, Inc. The facility will witness expansion with the flexibility to produce clinical as well as commercial cell therapies, such as allogeneic T-cell and CAR T immunotherapies.
The initiation of new businesses to remain competitive in the market through collaborations and partnerships can help accelerate the development of new platforms for cell and gene therapy manufacturing services. Thus, these strategic initiatives by key players are anticipated to create substantial growth opportunities in the South & Central America cell and gene therapy market during the forecast period.
South & Central America Cell and Gene Therapy Market Overview
Both profit and nonprofit organizations are propelling advanced medical product access and development in Brazil. In March 2024, for example, the Brazilian government's Funda??o Oswaldo Cruz (Fiocruz), a foundation under the Ministry of Health in Brazil, partnered with Caring Cross, a 501(c)(3) nonprofit organization committed to advancing the development of cutting-edge medical treatments and facilitating access to all patients worldwide. Under this partnership, the government aims to establish local production of chimeric antigen receptor (CAR)-T cell and stem cell gene therapies for patients suffering from oncology, infectious, and genetic diseases in Brazil. These therapies also include CAR-T cell therapies for leukemia, lymphoma, and HIV infection. Brazil is attempting a novel collaboration between the Ministry of Health of Brazil and Fiocruz, the public health and research foundation. Therefore, a rise in the initiatives undertaken by profit and nonprofit organizations propel the market growth in the coming years.
South & Central America Cell and Gene Therapy Market Revenue and Forecast to 2031 (US$ Million)
South & Central America Cell and Gene Therapy Market Segmentation
The South & Central America cell and gene therapy market is categorized into type, services, scale, end user, and country.
Based on type, the South & Central America cell and gene therapy market is bifurcated into cell therapy and gene therapy. The cell therapy segment held a larger market share in 2023. Furthermore, the cell therapy segment is sub segmented into allogeneic, autologous, viral vectors. Additionally, the gene therapy segment is divided into non-viral vectors and viral vectors.
In terms of services, the South & Central America cell and gene therapy market is categorized process development, cGMP manufacturing, regulatory services, and bioassay services. The process development segment held the largest market share in 2023.
By scale, the South & Central America cell and gene therapy market is bifurcated into pre-commercial/R&D manufacturing and commercial scale manufacturing. The pre-commercial/R&D manufacturing segment held a larger market share in 2023.
Based on end user, the South & Central America cell and gene therapy market is segmented into contract research, organizations, pharmaceutical and biopharmaceutical companies, and academic and research institutes. The pharmaceutical and biopharmaceutical companies segment held the largest market share in 2023.
By country, the South & Central America cell and gene therapy market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America cell and gene therapy market share in 2023.
Catalent Inc, Charles River Laboratories International In, F. Hoffmann-La Roche Ltd, FUJIFILM Holdings Corp, Lonza Group AG, Lotte Corp, Merck KGaA, Takara Bio Inc, and Thermo Fisher Scientific Inc. are some of the leading companies operating in the South & Central America cell and gene therapy market.
Reason to buy
Strategic Initiatives by Companies Boost South & Central America Cell and Gene Therapy Market
Many companies involved in manufacturing cell and gene therapy products focus on collaborations, expansions, agreements, partnerships, new product launches, and other strategic developments. These strategic initiatives help them improve sales, expand geographic reach, and enhance capacities to cater to a large customer base. A few of the significant developments in the cell and gene therapy market are as In March 2022, Cellevolve Bio partnered with Seattle Children’s Therapeutics to develop and commercialize new multiplex CARs for pediatric cancers. With this collaboration, the companies will focus on the BrainChild research program—a suite of five multiplex CARs—to treat pediatric central nervous system (CNS) malignancies. They aim to leverage the Seattle Children’s Cure Factory facility to conduct early clinical GMP research on new CARs. In March 2022, Twist Bioscience Corporation and Kriya Therapeutics, Inc. entered an antibody discovery agreement for antibodies delivered using adeno-associated viral (AAV) gene therapy in therapeutic oncology applications. Also, the companies aim to combine Twist’s antibody libraries with Kriya’s proprietary vector engineering platform to discover novel antibodies against specific targets of interest to be delivered with Kriya’s gene therapy technology. In January 2022, FUJIFILM Corporation agreed to acquire a cell therapy manufacturing facility from Atara Biotherapeutics, Inc. The facility will witness expansion with the flexibility to produce clinical as well as commercial cell therapies, such as allogeneic T-cell and CAR T immunotherapies.
The initiation of new businesses to remain competitive in the market through collaborations and partnerships can help accelerate the development of new platforms for cell and gene therapy manufacturing services. Thus, these strategic initiatives by key players are anticipated to create substantial growth opportunities in the South & Central America cell and gene therapy market during the forecast period.
South & Central America Cell and Gene Therapy Market Overview
Both profit and nonprofit organizations are propelling advanced medical product access and development in Brazil. In March 2024, for example, the Brazilian government's Funda??o Oswaldo Cruz (Fiocruz), a foundation under the Ministry of Health in Brazil, partnered with Caring Cross, a 501(c)(3) nonprofit organization committed to advancing the development of cutting-edge medical treatments and facilitating access to all patients worldwide. Under this partnership, the government aims to establish local production of chimeric antigen receptor (CAR)-T cell and stem cell gene therapies for patients suffering from oncology, infectious, and genetic diseases in Brazil. These therapies also include CAR-T cell therapies for leukemia, lymphoma, and HIV infection. Brazil is attempting a novel collaboration between the Ministry of Health of Brazil and Fiocruz, the public health and research foundation. Therefore, a rise in the initiatives undertaken by profit and nonprofit organizations propel the market growth in the coming years.
South & Central America Cell and Gene Therapy Market Revenue and Forecast to 2031 (US$ Million)
South & Central America Cell and Gene Therapy Market Segmentation
The South & Central America cell and gene therapy market is categorized into type, services, scale, end user, and country.
Based on type, the South & Central America cell and gene therapy market is bifurcated into cell therapy and gene therapy. The cell therapy segment held a larger market share in 2023. Furthermore, the cell therapy segment is sub segmented into allogeneic, autologous, viral vectors. Additionally, the gene therapy segment is divided into non-viral vectors and viral vectors.
In terms of services, the South & Central America cell and gene therapy market is categorized process development, cGMP manufacturing, regulatory services, and bioassay services. The process development segment held the largest market share in 2023.
By scale, the South & Central America cell and gene therapy market is bifurcated into pre-commercial/R&D manufacturing and commercial scale manufacturing. The pre-commercial/R&D manufacturing segment held a larger market share in 2023.
Based on end user, the South & Central America cell and gene therapy market is segmented into contract research, organizations, pharmaceutical and biopharmaceutical companies, and academic and research institutes. The pharmaceutical and biopharmaceutical companies segment held the largest market share in 2023.
By country, the South & Central America cell and gene therapy market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America cell and gene therapy market share in 2023.
Catalent Inc, Charles River Laboratories International In, F. Hoffmann-La Roche Ltd, FUJIFILM Holdings Corp, Lonza Group AG, Lotte Corp, Merck KGaA, Takara Bio Inc, and Thermo Fisher Scientific Inc. are some of the leading companies operating in the South & Central America cell and gene therapy market.
Reason to buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America cell and gene therapy market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the South & Central America cell and gene therapy market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America cell and gene therapy market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
- Catalent Inc
- Charles River Laboratories International Inc
- F. Hoffmann-La Roche Ltd
- FUJIFILM Holdings Corp
- Lonza Group AG
- Lotte Corp
- Merck KGaA
- Takara Bio Inc
- Thermo Fisher Scientific Inc.
1. INTRODUCTION
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. CELL AND GENE THERAPY MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
5. SOUTH & CENTRAL AMERICA CELL AND GENE THERAPY MARKET - KEY MARKET DYNAMICS
5.1 Cell and Gene Therapy Market - Key Market Dynamics
5.2 Market Drivers
5.2.1 Increase in Number of Approval of Cell and Gene Therapies
5.2.2 Rapid Popularity of Outsourcing Cell and Gene Therapy Manufacturing
5.3 Market Restraints
5.3.1 High Cost of Cell and Gene Therapy Manufacturing
5.4 Market Opportunities
5.4.1 Strategic Initiatives by Companies
5.5 Future Trends
5.5.1 Automation of Cell and Gene Therapy Manufacturing Services
5.6 Impact of Drivers and Restraints:
6. CELL AND GENE THERAPY MARKET -SOUTH & CENTRAL AMERICA MARKET ANALYSIS
6.1 Cell and Gene Therapy Market Revenue (US$ Million), 2021-2031
6.2 Cell and Gene Therapy Market Forecast Analysis
7. SOUTH & CENTRAL AMERICA CELL AND GENE THERAPY MARKET ANALYSIS - BY TYPE
7.1 Cell Therapy
7.1.1 Overview
7.1.2 Cell Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Gene Therapy
7.2.1 Overview
7.2.2 Gene Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
8. SOUTH & CENTRAL AMERICA CELL AND GENE THERAPY MARKET ANALYSIS - BY SERVICES
8.1 Process Development
8.1.1 Overview
8.1.2 Process Development: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
8.2 cGMP Manufacturing
8.2.1 Overview
8.2.2 cGMP Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Regulatory Services
8.3.1 Overview
8.3.2 Regulatory Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Bioassay Services
8.4.1 Overview
8.4.2 Bioassay Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
9. SOUTH & CENTRAL AMERICA CELL AND GENE THERAPY MARKET ANALYSIS - BY SCALE
9.1 Pre-Commercial/R&D Manufacturing
9.1.1 Overview
9.1.2 Pre-Commercial/R&D Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Commercial Scale Manufacturing
9.2.1 Overview
9.2.2 Commercial Scale Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
10. SOUTH & CENTRAL AMERICA CELL AND GENE THERAPY MARKET ANALYSIS - BY SERVICE PROVIDERS
10.1 CDMOs
10.1.1 Overview
10.1.2 CDMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
10.2 CMOs
10.2.1 Overview
10.2.2 CMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
11. SOUTH & CENTRAL AMERICA CELL AND GENE THERAPY MARKET ANALYSIS - BY END USER
11.1 Contract Research Organizations
11.1.1 Overview
11.1.2 Contract Research Organizations: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
11.2 Pharmaceutical and Biopharmaceutical Companies
11.2.1 Overview
11.2.2 Pharmaceutical and Biopharmaceutical Companies: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Academic and Research Institutes
11.3.1 Overview
11.3.2 Academic and Research Institutes: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12. CELL AND GENE THERAPY MARKET - COUNTRY ANALYSIS
12.1 South and Central America Cell and Gene Therapy Market, by Key Countries - Revenue (2023) (US$ Million)
12.1.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
12.1.1.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
12.1.1.2 Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.2.1 Brazil: Cell and Gene Therapy Market Breakdown, by Type
12.1.1.2.1.1 Brazil: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.1.1.2.1.2 Brazil: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.1.1.2.2 Brazil: Cell and Gene Therapy Market Breakdown, by Services
12.1.1.2.3 Brazil: Cell and Gene Therapy Market Breakdown, by Scale
12.1.1.2.4 Brazil: Cell and Gene Therapy Market Breakdown, by Service Providers
12.1.1.2.5 Brazil: Cell and Gene Therapy Market Breakdown, by End User
12.1.1.3 Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.3.1 Argentina: Cell and Gene Therapy Market Breakdown, by Type
12.1.1.3.1.1 Argentina: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.1.1.3.1.2 Argentina: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.1.1.3.2 Argentina: Cell and Gene Therapy Market Breakdown, by Services
12.1.1.3.3 Argentina: Cell and Gene Therapy Market Breakdown, by Scale
12.1.1.3.4 Argentina: Cell and Gene Therapy Market Breakdown, by Service Providers
12.1.1.3.5 Argentina: Cell and Gene Therapy Market Breakdown, by End User
12.1.1.4 Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.4.1 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Type
12.1.1.4.1.1 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.1.1.4.1.2 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.1.1.4.2 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Services
12.1.1.4.3 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Scale
12.1.1.4.4 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Service Providers
12.1.1.4.5 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by End User
13. INDUSTRY LANDSCAPE
13.1 Overview
13.2 Growth Strategies in Cell and Gene Therapy Market
13.3 Organic Growth Strategies
13.3.1 Overview
13.4 Inorganic Growth Strategies
13.4.1 Overview
14. COMPANY PROFILES
14.1 Thermo Fisher Scientific Inc.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Merck KGaA
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Charles River Laboratories International Inc
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Lonza Group AG
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Takara Bio Inc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 FUJIFILM Holdings Corp
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 F. Hoffmann-La Roche Ltd
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Catalent Inc
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Lotte Corp
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
15. APPENDIX
15.1 About The Insight Partners
15.2 Glossary of Terms
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. CELL AND GENE THERAPY MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
5. SOUTH & CENTRAL AMERICA CELL AND GENE THERAPY MARKET - KEY MARKET DYNAMICS
5.1 Cell and Gene Therapy Market - Key Market Dynamics
5.2 Market Drivers
5.2.1 Increase in Number of Approval of Cell and Gene Therapies
5.2.2 Rapid Popularity of Outsourcing Cell and Gene Therapy Manufacturing
5.3 Market Restraints
5.3.1 High Cost of Cell and Gene Therapy Manufacturing
5.4 Market Opportunities
5.4.1 Strategic Initiatives by Companies
5.5 Future Trends
5.5.1 Automation of Cell and Gene Therapy Manufacturing Services
5.6 Impact of Drivers and Restraints:
6. CELL AND GENE THERAPY MARKET -SOUTH & CENTRAL AMERICA MARKET ANALYSIS
6.1 Cell and Gene Therapy Market Revenue (US$ Million), 2021-2031
6.2 Cell and Gene Therapy Market Forecast Analysis
7. SOUTH & CENTRAL AMERICA CELL AND GENE THERAPY MARKET ANALYSIS - BY TYPE
7.1 Cell Therapy
7.1.1 Overview
7.1.2 Cell Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Gene Therapy
7.2.1 Overview
7.2.2 Gene Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
8. SOUTH & CENTRAL AMERICA CELL AND GENE THERAPY MARKET ANALYSIS - BY SERVICES
8.1 Process Development
8.1.1 Overview
8.1.2 Process Development: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
8.2 cGMP Manufacturing
8.2.1 Overview
8.2.2 cGMP Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Regulatory Services
8.3.1 Overview
8.3.2 Regulatory Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Bioassay Services
8.4.1 Overview
8.4.2 Bioassay Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
9. SOUTH & CENTRAL AMERICA CELL AND GENE THERAPY MARKET ANALYSIS - BY SCALE
9.1 Pre-Commercial/R&D Manufacturing
9.1.1 Overview
9.1.2 Pre-Commercial/R&D Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Commercial Scale Manufacturing
9.2.1 Overview
9.2.2 Commercial Scale Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
10. SOUTH & CENTRAL AMERICA CELL AND GENE THERAPY MARKET ANALYSIS - BY SERVICE PROVIDERS
10.1 CDMOs
10.1.1 Overview
10.1.2 CDMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
10.2 CMOs
10.2.1 Overview
10.2.2 CMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
11. SOUTH & CENTRAL AMERICA CELL AND GENE THERAPY MARKET ANALYSIS - BY END USER
11.1 Contract Research Organizations
11.1.1 Overview
11.1.2 Contract Research Organizations: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
11.2 Pharmaceutical and Biopharmaceutical Companies
11.2.1 Overview
11.2.2 Pharmaceutical and Biopharmaceutical Companies: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Academic and Research Institutes
11.3.1 Overview
11.3.2 Academic and Research Institutes: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12. CELL AND GENE THERAPY MARKET - COUNTRY ANALYSIS
12.1 South and Central America Cell and Gene Therapy Market, by Key Countries - Revenue (2023) (US$ Million)
12.1.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
12.1.1.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
12.1.1.2 Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.2.1 Brazil: Cell and Gene Therapy Market Breakdown, by Type
12.1.1.2.1.1 Brazil: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.1.1.2.1.2 Brazil: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.1.1.2.2 Brazil: Cell and Gene Therapy Market Breakdown, by Services
12.1.1.2.3 Brazil: Cell and Gene Therapy Market Breakdown, by Scale
12.1.1.2.4 Brazil: Cell and Gene Therapy Market Breakdown, by Service Providers
12.1.1.2.5 Brazil: Cell and Gene Therapy Market Breakdown, by End User
12.1.1.3 Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.3.1 Argentina: Cell and Gene Therapy Market Breakdown, by Type
12.1.1.3.1.1 Argentina: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.1.1.3.1.2 Argentina: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.1.1.3.2 Argentina: Cell and Gene Therapy Market Breakdown, by Services
12.1.1.3.3 Argentina: Cell and Gene Therapy Market Breakdown, by Scale
12.1.1.3.4 Argentina: Cell and Gene Therapy Market Breakdown, by Service Providers
12.1.1.3.5 Argentina: Cell and Gene Therapy Market Breakdown, by End User
12.1.1.4 Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.4.1 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Type
12.1.1.4.1.1 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.1.1.4.1.2 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.1.1.4.2 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Services
12.1.1.4.3 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Scale
12.1.1.4.4 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Service Providers
12.1.1.4.5 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by End User
13. INDUSTRY LANDSCAPE
13.1 Overview
13.2 Growth Strategies in Cell and Gene Therapy Market
13.3 Organic Growth Strategies
13.3.1 Overview
13.4 Inorganic Growth Strategies
13.4.1 Overview
14. COMPANY PROFILES
14.1 Thermo Fisher Scientific Inc.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Merck KGaA
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Charles River Laboratories International Inc
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Lonza Group AG
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Takara Bio Inc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 FUJIFILM Holdings Corp
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 F. Hoffmann-La Roche Ltd
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Catalent Inc
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Lotte Corp
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
15. APPENDIX
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. Cell and Gene Therapy Market Segmentation
Table 2. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Table 3. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Type
Table 4. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Cell Therapy
Table 5. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Gene Therapy
Table 6. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Services
Table 7. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Scale
Table 8. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Service Providers
Table 9. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 10. South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Country
Table 11. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 12. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 13. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 14. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 15. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 16. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 17. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 18. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 19. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 20. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 21. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 22. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 23. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 24. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 25. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 26. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 27. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 28. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 29. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 30. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 31. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 32. Recent Organic Growth Strategies in Cell and Gene Therapy Market
Table 33. Recent Inorganic Growth Strategies in the Cell and Gene Therapy Market
Table 34. Glossary of Terms
Table 1. Cell and Gene Therapy Market Segmentation
Table 2. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Table 3. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Type
Table 4. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Cell Therapy
Table 5. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Gene Therapy
Table 6. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Services
Table 7. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Scale
Table 8. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Service Providers
Table 9. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 10. South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Country
Table 11. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 12. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 13. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 14. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 15. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 16. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 17. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 18. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 19. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 20. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 21. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 22. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 23. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 24. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 25. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 26. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 27. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 28. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 29. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 30. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 31. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 32. Recent Organic Growth Strategies in Cell and Gene Therapy Market
Table 33. Recent Inorganic Growth Strategies in the Cell and Gene Therapy Market
Table 34. Glossary of Terms
LIST OF FIGURES
Figure 1. Cell and Gene Therapy Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Cell and Gene Therapy Market Revenue (US$ Million), 2021-2031
Figure 5. Cell and Gene Therapy Market Share (%) - by Type (2023 and 2031)
Figure 6. Cell Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Gene Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Cell and Gene Therapy Market Share (%) - by Services (2023 and 2031)
Figure 9. Process Development: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. cGMP Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Regulatory Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Bioassay Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Cell and Gene Therapy Market Share (%) - by Scale (2023 and 2031)
Figure 14. Pre-Commercial/R&D Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Commercial Scale Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Cell and Gene Therapy Market Share (%) - by Service Providers (2023 and 2031)
Figure 17. CDMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. CMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Cell and Gene Therapy Market Share (%) - by End User (2023 and 2031)
Figure 20. Contract Research Organizations: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 21. Pharmaceutical and Biopharmaceutical Companies: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 22. Academic and Research Institutes: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 24. South and Central America: Cell and Gene Therapy Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 25. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 26. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 27. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 28. Growth Strategies in Cell and Gene Therapy Market
Figure 1. Cell and Gene Therapy Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Cell and Gene Therapy Market Revenue (US$ Million), 2021-2031
Figure 5. Cell and Gene Therapy Market Share (%) - by Type (2023 and 2031)
Figure 6. Cell Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Gene Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Cell and Gene Therapy Market Share (%) - by Services (2023 and 2031)
Figure 9. Process Development: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. cGMP Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Regulatory Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Bioassay Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Cell and Gene Therapy Market Share (%) - by Scale (2023 and 2031)
Figure 14. Pre-Commercial/R&D Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Commercial Scale Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Cell and Gene Therapy Market Share (%) - by Service Providers (2023 and 2031)
Figure 17. CDMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. CMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Cell and Gene Therapy Market Share (%) - by End User (2023 and 2031)
Figure 20. Contract Research Organizations: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 21. Pharmaceutical and Biopharmaceutical Companies: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 22. Academic and Research Institutes: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 24. South and Central America: Cell and Gene Therapy Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 25. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 26. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 27. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 28. Growth Strategies in Cell and Gene Therapy Market
